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CENTRAL VENOUS ACCESS SYSTEM 
CROSS REFERENCE TO RELATED CASES 
The present application is a division of U.S. patent 
application Ser. No. 12/958,702 filed Dec. 2, 2010, which 
claims the benefit of both U.S. Provisional Application 
61/363,436 entitled "CENTRAL VENOUS ACCESS 
METHOD, SYSTEM and DEVICES" filed 12 Jul. 2010; 
and U.S. Provisional Application 61/266,298 entitled 
"INSIDE/OUT CENTRAL VENOUS ACCESS and APPA-
RATUS" filed 3 Dec. 2009. The entire contents of each of 
the above-referenced disclosures are specifically incorpo-
rated herein by reference without disclaimer. 
BACKGROUND OF THE INVENTION 
2 
With the needle wire pushed through the skin and exte-
riorized, companion devices are pushed and/or pulled 
through the tissue track enlarging it and preparing it for the 
placement of an access port or pacing lead or the like. The 
combination of pushing and pulling motions enabled by the 
catheter system allows for the safe and quick access or 
re-acquisition of a lost access site to the central venous 
system. In many instances the ability to work close to 
thrombus and near occlusions with great precision allows 
10 the recovery or salvage of an otherwise lost venous access 
location, which is a sig n if icant benefit to the patient. 
15 
DESCRIPTION OF THE DRAWINGS 
In the several fig ures of the drawings, identical reference 
Central venous access (CVA) is one of the most com-
monly performed procedures in medicine. CVA is vital to 
many patients with acute and chronic illness. Hemodialysis 20 
and cardiac pacing are examples of life-sustaining therapies 
that would not be possible without central venous access. 
numerals are used to identify identical or equivalent struc-
ture wherein: 
FIG. 1 is a schematic diagram showing a portion of the 
venous system of a patient; 
FIG. 2A is a plan view schematic diagram showing the 
use of a catheter system to access the central venous system; 
FIG. 2B  is a cross-sectional schematic diagram 
showing a side view of the system of FIG. 2A; CVA is typically obtained by using a large gauge needle 
to directly puncture first the skin and then one of the four 
large upper body veins, for example, the right or left internal 
jugular vein, or the right or left subclavian vein. After 
puncture, a guidewire is introduced through the needle and 
advanced into the central circulation. The channel is then 
dilated and a catheter or other medical device is advanced 
into the superior vena cava (SVC) or right atrium (RA). 
Although central venous access is usually a straightfor-
ward procedure, there can be both short term and long term 
complications. Immediate risks include bleeding due to 
FIG. 3 is a schematic representation of the distal ends of 
25 elements of the catheter system; 
FIG. 4 is a schematic diagram showing an assembly of the 
proximal ends of the catheter system; 
30 
FIG. 5 is a schematic depiction of a step in the process and 
illustrates the function of an element of the catheter system; 
FIG. 6 is a schematic depiction of a step in the process and 
illustrates the function of an element of the catheter system; 
FIG. 7 is a schematic depiction of a step in the process and 
illustrates the function of an element of the catheter system; 
FIG. 8 is a schematic depiction of a step in the process and 
35 illustrates the function of an element of the catheter system; 
FIG. 9 is a schematic depiction of a step in the process and 
illustrates the function of an element of the catheter system; 
FIG. 10 is a schematic depiction of a step in the process 
and illustrates the function of an element of the catheter 
40 system; 
FIG. 11 is a schematic depiction of a step in the process 
and illustrates the function of an element of the catheter 
system; 
FIG. 12 is a schematic depiction of a step in the process 
45 and illustrates the function of an element of the catheter 
inadvertent puncture of carotid or subclavian arteries, and 
pneumothorax due to unintended puncture of  a lung. These 
complications occur because central veins lie deep beneath 
the skin and are therefore not visible to the operator. As a 
result, there is often uncertainty about the location, depth 
and entry angle of the puncture needle, even when ultra-
sound guidance is used. The long-term risks of central 
access include venous occlusion, which can occur within 
days and is a common problem in patients requiring 
repeated access or semi-permanent access. Chronic 
venous occlu-sions occur when thrombus forms around 
a catheter or pacing lead, and then organizes into dense 
fibrous tissue that permanently obliterates the vessel lumen. 
When confronted with occlusion of a central vein, phy-
sicians usually utilize one of the remaining veins in the 
upper body. The process can continue until all four central 
veins have been obliterated. However, once all four upper 50 
body central veins are lost the patient can have a life 
threatening access crisis. 
system; 
FIG. 13 is a schematic depiction of a step in the process 
and illustrates the function of an element of the catheter 
system; 
FIG. 14 is a schematic depiction of a step in the process 
and illustrates the function of an element of the catheter 
system, and; 
SUMMARY OF THE INVENTION 
FIG. 15 is a schematic depiction of a step in the process 
and illustrates the function of an element of the catheter 
55 system. 
The method is carried out by intravascular navigation of 
a catheter system that includes specialized devices serving 
multiple functions. An exit point target site is identified for 
example near the clavicle on the exterior of the patient's 
body. The specialized set of intravascular devices in the 60 
catheter system are navigated from a remote entry point for 
example, in the groin to a position proximate the desired exit 
point target site. A very sharp needle wire is pushed through 
the catheter system and is directed by the catheter system in 
a defined and desired direction. Passage of this needle wire 65 
forms an extra-vascular tissue track from the vessel to the 
skin near the exit point target site. 
DETAILED DESCRIPTION OF THE 
INVENTION 
One of the most clinically significant uses of the devices 
and methods of this invention pertains to right-sided supra-
clavicular access because it combines the preferred location 
for long-term catheters, the most common site of chronic 
venous occlusions, and the most straightforward application 
of the invention. Therefore this procedure has been selected 
as an illustrative but not limiting example of the techniques 
and suitable hardware implementations of the catheter sys-
US 10,004,879 B2 
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FIG. 3 shows the distal tips of various elements of the 
catheter system assembled in various configurations or com-
binations in several panels. The relatively long rigid guide 
catheter work station 30 can support various devices within 
its working lumen 31. It is expected that suitable perfor-
mance can be achieved by manufacturing the rigid guide 
catheter 30 with conventional techniques well known in the 
art in a diameter of about SF permitting the device to 
delivered through an SF introducer. Both metal and braided 
10 structures are expected to be suitable. 
In the figure the dilation stylet 42 is shown within the 
lumen 31 of the rigid guide catheter work station 30. The 
dilation stylet 42 is free to move within the lumen 31. 
15 Depending on the point in procedure, the central working 
lumen 43 of the dilation stylet 42 may carry and support 
either the canalization wire 48 or the needle wire directional 
guide 40. The needle wire directional guide 40 has a central 
lumen 41 adapted to receive the needle wire 46. The distal 
20 tip of the needle wire 46 is quite sharp and acts like a trocar 
to cut and divide tissue as it is pushed. The stiffness of the 
device and its sharpness must be selected so that it can be 
pushed through tissue. A sharpened nitinol. 014 wire has 
approximately the correct properties for the needle wire. 
25 Note as well that the distal tip of the needle wire directional 
guide 40 forms a gentle curve 47 to direct and deflect the 
needle wire 46 in a specific direction. It is expected that this 
portion of the device will be manufactured from a shape 
memory material such as nitinol, with the gentle curve 47 
30 formed where the needle wire directional guide 40 emerges 
tern invention. The invention is illustrated in the context of 
a patient having an occluded right internal jugular vein 
which is recovered by use of  the method and catheter system 
to place a new access point near the one lost to the occlusion. 
In contrast to the conventional practice that would sacrifice 
companion vessels, the illustration achieves re-entry very 
near a lost CVA location. 
FIG. 1 shows the context of the invention and presents the 
interventional path with respect to certain anatomic refer-
ence points. FIG. 2A and FIG. 2B should be considered 
together and together they show the placement of the rigid 
guide catheter work station with regard to preferred ana-
tomic reference points. FIG. 2A also shows the proximal end 
portions of elements of the catheter system extending out of 
the patient's body. FIG. 3 shows the distal end portions of 
catheter system elements. FIG. 4 shows the proximal ends of 
catheter systems elements. The intermediate portions of the 
catheter elements are not shown for clarity but they should 
be understood to continue from the distal to the proximal 
ends and have overall lengths suitable for the size of the 
patient, and will be on the order of 200 cm overall or more 
for an adult case. FIG. 5 through FIG. 15 depicts steps in an 
illustrative fashion of a method of using the catheter system. 
FIG. 1 shows a patient 10 with an occluded right internal 
jugular vein indicated by the cross-hatched occlusion in the 
vessel at reference numeral 12. The method and devices of 
the invention are used to re-acquire access to the central 
venous system through an exit point target location 16 near 
and slightly above the collar bone or clavicle 14. Beginning 
at a remote entry point 18 near a large femoral vein in the 
groin of the patient, the interventional path is seen as a 
dashed line at reference numeral 20. In practice the surgeon 
will use conventional techniques to enter the femoral vein 
then introduce the inventive catheter system and use it to 
follow the interventional path 20 forming an  exit  through the    
skin of the body near the clavicle at the exit point 16 in this 
illustrative description. Once an appropriate tissue track is 
from the distal tip of the dilation stylet 42. The gentle curve 
will direct the needle wire through an angle near 90 degrees 
or so. 
FIG. 4 shows the proximal ends of some of the compo-
nents assembled into working configurations. In general, the 
rigid guide catheter work station 30 is placed at the correct 
location previously described and it remains largely station-
ary once positioned. An associated valve and flush port with 
Luer fittings is provided to introduce fluids to clear the 
40 devices and occasionally introduce contrast agent. The 
hemostasis valve and flush valve are shown schematically 
labeled 37 in the figure. Operation and configuration will be 
described in more detail in the steps of the method. 
established between the exit location 16 and the central 
venous system the tissue track will be prepared for the 
delivery of a conventional CVA access port or other device 
concluding the access procedure. 
FIG. 2A is a schematic illustration depicting the place-
ment of the rigid guide catheter work station 30 placed along 
the interventional path with the distal tip 33 of the work 
station located above the right atrium 32 at about the level 
of the ostium of the azygos vein seen at 36. The exit target 
location is shown at 16 and the remote entry point is shown 
at 18. Proximal portions of the catheter system extend out of 
the groin area and they are collectively labeled 17. The 
physician manipulates these proximal ends of elements of 
the catheter system rotating, retracting and advancing them 
to navigate through the vasculature, while observing the 
locations of the distal ends of the devices under fluoroscopy. 
FIG. 2B is a schematic cross section of the patient with 
anatomic landmarks called out in the figure showing the 
placement of the rigid guide catheter work station 30, and is 
a side view of FIG. 2A. The figure shows successful 
deflection anteriorly of the rigid guide catheter work station 
FIG. 5 shows a step in the method. As a prelude to this 
45 step the entry and exit points on the skin of the patient will 
be identified and perhaps marked. Next the vascualture will 
have been accessed via a conventional Seldinger procedure. 
At his time the rigid guide catheter work station 30 is 
introduced over a wire into the venous circulation. The 
50 straightness of the vasculature and the straightness of the 
rigid guide catheter workstation 30 allow for navigation, 
indicated by arrow 51, of the distal end of the catheter 
workstation 30 to the preferred location in the figure above 
the right atrium RA 32, below the occlusion 12 and near the 
55 clavicle 14. 
FIG. 6 shows a step in the method. Next the dilation sty let 
42 is advanced out of the rigid catheter work station with the 
needle wire directional guide 40 to about the occlusion 12 
which is typically verified with a contrast injection. The 
physician manipulating the directional guide arm 45 aims 
the needle wire directional guide 40 so that the exit port 
lumen 41 points toward the exit location target site 16 
identified on the skin of the patient. Although it is difficult 
to illustrate the placement of the rigid guide catheter work 
station 30 it is placed along the anterior wall of the SVC so 
that the needle wire guide 40 and dilation stylet 42 can be 
advanced safely toward the occlusion without interfering 
30 at the junction of the IVC and RA 32. This places the 
60 distal tip 33 of the workstation against the anterior wall of 
the SVC. This forces or biases the distal tip 33 against the 
wall of the vessel and also protects posterior structures from 
involvement with the catheter system. Once this placement is 
achieved  the  work station 30 remains  relatively stationary 
during the rest of the procedure until it is ultimately removed 
from the body. 
35
60
65
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with other structures. At this point the needle wire direc-
tional guide port or lumen 41 is a short distance from the 
target exit point 16. 
6 
SUMMARY 
FIG. 7 shows a step in the method. With aiming com-
pleted the physician can push the wire clamp 50 (FIG. 4) to 
advance the needle wire 46 out of the lumen 41 of the needle 
wire directional guide 40 and dissect a tissue path toward the 
clavicle as indicated by force and motion arrow 53 defining 
an extra vascular tissue track. The rigidity of the rigid 
catheter work station 30 and its placement allow the reaction 
forces from the needle wire 46 advancement to be taken up 
the rigid guide catheter work station and dilation stylet 42 
and transferred to the body. The cross section of FIG. 28 
also depicts this step with the needle wire 46 actually 
exteriorized in that figure. 
The method and suite of devices that make up the catheter 
system can be used to acquire or re-acquire CVA allowing 
for the salvage or reuse of vessels and locations that are lost 
to conventional methods and devices. The method is depen-
dent upon the use of particular devices having specific 
qualities. The rigid guide catheter work station must be stiff 
enough to resist reaction forces supplied by the needle wire 
10 as it dissects tissue and establishes the tissue track. The 
needle wire must be stiff enough to dissect tissue when 
pushed from its proximal end. It must be stiff enough to not 
wander off course and a very sharp trocar like tip aids in 
FIG. 8 shows a step in the method. The physician con-
tinues to advance the needle wire 46 until it becomes 
exteriorized at the exit point 16. The small wound depicted 
at reference numeral 60 indicates the exit point. The needle 
wire 46 segment labeled 62 lies outside the body. 
15 minimizing the force required for dissection. The needle 
wire directional guide must not whip or kink while it is being 
aimed under X-ray guidance. 
It is also noted that there is much flexibility in the 
procedure and the system and apparatus used to carry out the 
FIG. 9 shows a step in the method. The physician will 
next clamp the needle wire 46 to the dilation stylet 42 with 
a wire clamp 50 or similar device at the proximal ends of the 
devices as depicted in FIG. 4. and apply traction to the 
exterior segment of the needle wire 62 pulling the dilation 
stylet 42 out of the body through the exit point enlarging the 
tissue track created by the passage of the needle wire 46. 
20 method. Some variation in the method will reflect operator 
preference or the state or size of the patient. For this reason 
the descriptions herein are intended to be illustrative and not 
limiting. In a similar fashion the set of specialized medical 
devices illustrated for carrying out the invention can be 
FIG. 10 shows a step in the method. The physician may 
next remove the needle wire 46 and the needle wire direc-
25 supplemented or truncated and certain functions can be 
carried out with alternate devices. As a consequence the 
description of the favored hardware should be considered 
illustrative and not limiting. 
tional guide 40 leaving the dilation stylet exteriorized and its 30 
central lumen 43 empty. 
FIG. 11 shows a step in the method. With the dilation 
sty let 42 exposed outside the patient the physician may then 
load or backload a larger gauge wire such as a canalization 
wire 48 or other guide wire product into the lumen of the 35 
dilation stylet. This larger diameter wire will support the 
next stages of the intervention. The wire size and type is 
driven mostly by the device that is to be implanted. In the 
illustrative process a CVA dialysis type port is to be 
implanted using a conventional introducer sheath 64. 40 
FIG. 12 shows a step in the method. The physician may 
load the conventional introducer sheath 64 onto the canali-
zation wire 48 and clamp them together with a wire clamp 
What is claimed is: 
1. A method for acquiring access to the central venous
system of a patient at a target location near an occlusion of 
a jugular vein, comprising the steps of: 
introducing a guide catheter into a blood vessel at a 
location remote from said occlusion; 
advancing a needle wire having a sharp end transvascu-
larly through the guide catheter until its sharp end is 
adjacent the occlusion; 
rotationally adjusting said needle wire until its sharp end 
is aimed toward the desired skin exit location; 
advancing the needle wire to puncture the blood vessel 
from the inside out at a vascular exit site adjacent the 
occlusion, thereby establishing a tissue track; 
further advancing the needle wire along said tissue track 
thereby extending said tissue track to puncture the skin 
from the inside out near said vascular exit site. 
2. The method of claim 1 further including the steps of: 
enlarging said tissue track by sequential dilation. 
50 or the like. The physician has a choice of pulling the 
introducer along the extra vascular tissue track by tugging 45 
on the proximal portions of the dilation stylet and canaliza-
tion wire or pushing it along the tissue track from the distal 
end of the system or doing both sequentially or simultane-
ously. 3. The method of claim 2 wherein said enlarging step 
50 includes; FIG. 13 shows a step in the method. This figure shows the 
introducer sheath 64 placed into the central venous system 
just below the level of the occlusions thus salvaging the 
location. This figure shows the introducer 64 in place and the 
physician may remove the rigid guide catheter workstation 
and related devices from the femoral entry point. The 
physician may leave a guide wire in place depending on the 
course of the procedure. 
clamping said needle wire and said dilation sty let together 
and drawing them together from said target location. 
4. A method for acquiring access to the central venous
system of a patient near an occlusion, comprising the steps 
55 of: 
FIG. 14 shows a step in the method. The physician may 
access the lumen of the convention al introducer 64 to permit 
the insertion of the dialysis port 66, though the lumen of the 60 
introducer. The precise sequence and hemostasis manage-
ment will depend on the particularities of the port and the 
introducer and is not part of the invention apart from 
illustrating the utility of the procedure. 
FIG. 15 shows a dialysis port 66 placed in the patient via 65 
the catheter system and method. This port lies in a desirable 
location that would have been otherwise lost. 
identifying an exit point target site on the exterior skin of 
a patient near an occlusion; 
introducing a needle wire having a sha r p  end into a blood 
vessel at a location remote from said occlusion; 
advancing the needle wire through the vascalature until its 
sharp end is adjacent the occlusion; 
aiming the sharp end of the needle wire toward the exit 
point target; and 
advancing the needle wire through the occlusion and 
through the blood vessel until it becomes exteriorized 
at the exit point target to establish a tissue track from 
the blood vessel to the exterior of the patient. 
US 10,004,879 B2 
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5. The method of claim 4, further comprising introducing 
a guide catheter with a lumen into the patient at the location 
remote from the patient and advancing the guide catheter to 
the occlusion. 
6. The method of claim 5, comprising advancing a dilation 
stylet through the guide catheter to the occlusion, the dila-
tion stylet having a lumen for receiving the needle wire. 
7. The method of claim 6, further comprising pulling the 
dilation stylet out of the body through the exit point to 
enlarge the tissue track created by the needle wire. 
8. The method of claim 6, wherein the step of aiming the 
sharp end of the needle wire comprises rotating the dilation 
sty let. 
9. A method for acquiring access to the central venous 
system of a patient near an occlusion, comprising the steps 
of: 
identifying an exit point target site on the exterior skin of 
a patient near an occlusion; 
introducing a guide catheter having a first lumen into a 
blood vessel at a location remote from the exit point 
target site and advancing the guide catheter to the 
occlusion; 
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advancing a dilation sty let having a second lumen through 
the guide catheter lumen to the occlusion; advancing a 
needle wire with a sharpened end through the 
dilation stylet lumen so that the sharpened end is 
adjacent the occlusion; 
aiming the sharp end of the needle wire toward the exit 
point target; and 
advancing the needle wire through the occlusion and 
through the blood vessel until it becomes exteriorized 
at the exit point target to establish a tissue track from 
the blood vessel to the exterior of the patient. 
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10. The method of claim 9, wherein the remote site 
comprises a femoral vein in a groin of the patient. 
11. The method of claim 9, further comprising placing an 
introducer sheath in the tissue track. 
12. The method of claim 9, further comprising pulling the 
dilation stylet out of the body through the exit point to 
enlarge the tissue track created by the needle wire. 
13. The method of claim 12, further comprising introduc-
ing a canalization wire into the dilation stylet. 
* * * * *
